Day: April 28, 2026

Kestrel Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of KST-6051, a Potential Best-in-Class Pan-KRAS Inhibitor, in Patients with KRAS-driven Malignancies

Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy

- Orphan drug designation from the European Commission underscores Solid’s commitment to advance SGT-003 through a global development effort for...

BioCardia Announces Allowance of Japanese Patent on Proprietary Heart3D™ Fusion Imaging Software for Procedure Planning and Realtime Navigation During CardiAMP Cell Therapy Procedures

SUNNYVALE, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. , a global leader in cellular and cell-derived therapeutics for the...

Plus Therapeutics Secures Blue Shield of California Coverage for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Expands access by 6 million covered lives, advancing commercial momentum for CNSide® in metastatic CNS cancersHOUSTON, April 28, 2026 (GLOBE...

BridgeBio Launches Health Education Effort on Often Overlooked Heart Condition Featuring Attruby® Advocates, Morgan Freeman and Sports Business Icon Howard H. White

- New national campaign encourages recognition of ATTR-CM, often mistaken for other heart conditions, where earlier diagnosis and treatment may...

error: Content is protected !!